Centre allocates additional 19,420 vials of Amphotericin-B to States, UTs

In view of the rising Mucormycosis (commonly known as black fungus) cases across the country, the Ministry of Chemicals and Fertilizers on Tuesday informed that it has allocated 19,420 additional vials of Amphotericin-B to various States and Union Territories.

"Additional 19,420 vials of #Amphotericin-B have been allocated to all States/UTs and Central Institutions today. Besides this, 23680 vials of Amphotericin- B were allocated across country on 21st May", tweeted the Union Minister for Chemicals and Fertilizers, DV Sadananda Gowda.

Mucormycosis or black fungus is a fungal infection caused by exposure to mucor mould which is commonly found in soil, plants, manure, and decaying fruits and vegetables.

As of now, Amphotericin-B, an anti-fungal drug is being used for the treatment of the black fungus disease.

The Union Health Ministry, on May 20, urged the states to make mucormycosis, a notifiable disease under the Epidemic Diseases Act 1897. The central government has made it mandatory for states to report both suspected and confirmed cases of mucormycosis to the Integrated Disease Surveillance Programme (IDSP).

Cases of black fungus infection are being reported in several parts of the country. States like Rajasthan, Gujarat, Punjab, Haryana, Karnataka, Odisha, Telangana and Tamil Nadu have already declared it a 'notifiable' disease under the Epidemic Diseases Act, thereby making it mandatory to report every Mucormycosis case to the state government.

Delhi also reported more than 500 cases of black fungus till yesterday, as per Chief Minister Arvind Kejriwal.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel